# DiaMedica Therapeutics Inc.: Form 8-K, filed Feb 24, 2025

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2025-02-24
- Accepted by EDGAR: Feb 24, 2025, 16:30 ET
- Period: 2025-02-20
- Accession: 0001437749-25-004891
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774925004891/dmtp20250221_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774925004891/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774925004891/dmtp20250221_8k.htm

Filed Feb 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-004891. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.